BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16217848)

  • 1. A multiscale method for disease mapping in spatial epidemiology.
    Louie MM; Kolaczyk ED
    Stat Med; 2006 Apr; 25(8):1287-306. PubMed ID: 16217848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiscale detection of localized anomalous structure in aggregate disease incidence data.
    Louie MM; Kolaczyk ED
    Stat Med; 2006 Mar; 25(5):787-810. PubMed ID: 16453373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian disease mapping using product partition models.
    Hegarty A; Barry D
    Stat Med; 2008 Aug; 27(19):3868-93. PubMed ID: 18381710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial variation of mortality for common and rare cancers in Piedmont, Italy, from 1980 to 2000: a Bayesian approach.
    Maule M; Merletti F; Mirabelli D; La Vecchia C
    Eur J Cancer Prev; 2006 Apr; 15(2):108-16. PubMed ID: 16523007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple testing on standardized mortality ratios: a Bayesian hierarchical model for FDR estimation.
    Ventrucci M; Scott EM; Cocchi D
    Biostatistics; 2011 Jan; 12(1):51-67. PubMed ID: 20577014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The misuse of count data aggregated over time for disease mapping.
    OcaƱa-Riola R
    Stat Med; 2007 Oct; 26(24):4489-504. PubMed ID: 17335121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation in Bayesian disease mapping.
    MacNab YC; Farrell PJ; Gustafson P; Wen S
    Biometrics; 2004 Dec; 60(4):865-73. PubMed ID: 15606406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling disease incidence data with spatial and spatio temporal dirichlet process mixtures.
    Kottas A; Duan JA; Gelfand AE
    Biom J; 2008 Feb; 50(1):29-42. PubMed ID: 17926327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multivariate CAR model for improving the estimation of relative risks.
    Greco FP; Trivisano C
    Stat Med; 2009 May; 28(12):1707-24. PubMed ID: 19308933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An innovative application of Bayesian disease mapping methods to patient safety research: a Canadian adverse medical event study.
    MacNab YC; Kmetic A; Gustafson P; Sheps S
    Stat Med; 2006 Dec; 25(23):3960-80. PubMed ID: 16498611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian hierarchical model for the estimation of two incomplete surveillance data sets.
    Buenconsejo J; Fish D; Childs JE; Holford TR
    Stat Med; 2008 Jul; 27(17):3269-85. PubMed ID: 18314934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical Bayes estimation of small area prevalence of non-rare conditions.
    Martuzzi M; Elliott P
    Stat Med; 1996 Sep 15-30; 15(17-18):1867-73. PubMed ID: 8888479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of mixture models for identifying high risks in disease mapping.
    Militino AF; Ugarte MD; Dean CB
    Stat Med; 2001 Jul; 20(13):2035-49. PubMed ID: 11427958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of conditional autoregressive models used in Bayesian disease mapping.
    Lee D
    Spat Spatiotemporal Epidemiol; 2011 Jun; 2(2):79-89. PubMed ID: 22749587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping disability-adjusted life years: a Bayesian hierarchical model framework for burden of disease and injury assessment.
    MacNab YC
    Stat Med; 2007 Nov; 26(26):4746-69. PubMed ID: 17427183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis.
    McMahon PM; Zaslavsky AM; Weinstein MC; Kuntz KM; Weeks JC; Gazelle GS
    Med Decis Making; 2006; 26(5):497-511. PubMed ID: 16997927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian analysis of crossclassified spatial data with autocorrelation.
    Sun L; Clayton MK
    Biometrics; 2008 Mar; 64(1):74-84. PubMed ID: 17680834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient mapping of California mortality fields at different spatial scales.
    Choi KM; Serre ML; Christakos G
    J Expo Anal Environ Epidemiol; 2003 Mar; 13(2):120-33. PubMed ID: 12679792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling disease-state transition heterogeneity through Bayesian variable selection.
    Healy BC; Engler D
    Stat Med; 2009 Apr; 28(9):1353-68. PubMed ID: 19206077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.